Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Director Acquires $58,700.00 in Stock
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) Director John B. Bode bought 10,000 shares of the firm’s stock in a transaction on Friday, July 12th. The stock was purchased at an average cost of $5.87 per share, with a total value of $58,700.00. Following the completion of the transaction, the director now directly owns […]
More Stories
The Dollar Dilemma During Trump 2.0
By Andrew Moran The U.S. dollar suffered its worst first-half year performance since 1973. This year, the U.S. dollar index,...
No Caitlin Clark, No Problem for Fever in WNBA Commissioner’s Cup Win
By Matthew Davis The Indiana Fever won the WNBA Commissioner’s Cup on Tuesday and did it without Caitlin Clark on...
What to Know About Alligator Alcatraz: The Deportation Center Surrounded by 30,000 Alligators
By T.J. Muscaro Deep in the Florida Everglades, the latest illegal immigration detention and deportation facility opened for business on...
Rain, Thunderstorms Expected to Dampen Fourth of July for Parts of Gulf
By T.J. Muscaro TAMPA BAY, Fla.—People looking to celebrate the Fourth of July on the Gulf along Florida’s Peninsula should...
Universal Basic Income Is Coming: Are We Ready for a Jobless Future
By Stephen Zogopoulos, USNN World News In a world racing toward automation, Elon Musk—a man who’s rarely wrong when it...
Is Temu Legit? Honest Reviews, Pros, Cons & Alternatives
In this era of fast fashion, Temu is a top contender in the American market. Giving tough competition to marketplace...